Pediatric in vitro and in silico models of deposition via oral and nasal inhalation
- PMID: 24870701
- DOI: 10.1089/jamp.2013.1075
Pediatric in vitro and in silico models of deposition via oral and nasal inhalation
Abstract
Respiratory tract deposition models provide a useful method for optimizing the design and administration of inhaled pharmaceutical aerosols, and can be useful for estimating exposure risks to inhaled particulate matter. As aerosol must first pass through the extrathoracic region prior to reaching the lungs, deposition in this region plays an important role in both cases. Compared to adults, much less extrathoracic deposition data are available with pediatric subjects. Recently, progress in magnetic resonance imaging and computed tomography scans to develop pediatric extrathoracic airway replicas has facilitated addressing this issue. Indeed, the use of realistic replicas for benchtop inhaler testing is now relatively common during the development and in vitro evaluation of pediatric respiratory drug delivery devices. Recently, in vitro empirical modeling studies using a moderate number of these realistic replicas have related airway geometry, particle size, fluid properties, and flow rate to extrathoracic deposition. Idealized geometries provide a standardized platform for inhaler testing and exposure risk assessment and have been designed to mimic average in vitro deposition in infants and children by replicating representative average geometrical dimensions. In silico mathematical models have used morphometric data and aerosol physics to illustrate the relative importance of different deposition mechanisms on respiratory tract deposition. Computational fluid dynamics simulations allow for the quantification of local deposition patterns and an in-depth examination of aerosol behavior in the respiratory tract. Recent studies have used both in vitro and in silico deposition measurements in realistic pediatric airway geometries to some success. This article reviews the current understanding of pediatric in vitro and in silico deposition modeling via oral and nasal inhalation.
Keywords: benchtop models; child; computational fluid dynamics; empirical correlations; exposure risk assessment; infant; inhalation toxicology; inhaled pharmaceutical aerosol; mathematical models.
Similar articles
-
In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S59-69. doi: 10.1089/jamp.2010.0846. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 21133801 Review.
-
Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model.J Aerosol Med Pulm Drug Deliv. 2014 Jun;27(3):209-18. doi: 10.1089/jamp.2013.1051. Epub 2013 Jun 29. J Aerosol Med Pulm Drug Deliv. 2014. PMID: 23808762
-
Inspiratory and expiratory aerosol deposition in the upper airway.Inhal Toxicol. 2011 Feb;23(2):104-11. doi: 10.3109/08958378.2010.547535. Inhal Toxicol. 2011. PMID: 21309663
-
Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.AAPS PharmSciTech. 2014 Jun;15(3):630-40. doi: 10.1208/s12249-014-0092-0. Epub 2014 Feb 22. AAPS PharmSciTech. 2014. PMID: 24563174 Free PMC article. Review.
-
Intranasal Filtration of Inhaled Aerosol in Human Subjects as a Function of Nasal Pressure Drop.J Aerosol Med Pulm Drug Deliv. 2019 Feb;32(1):13-23. doi: 10.1089/jamp.2018.1476. Epub 2018 Sep 10. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 30199315
Cited by
-
Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) in the United States in 2019.JAMA Pediatr. 2020 Jul 1;174(7):e200756. doi: 10.1001/jamapediatrics.2020.0756. Epub 2020 Jul 6. JAMA Pediatr. 2020. PMID: 32421164 Free PMC article.
-
Variability in Nose-to-Lung Aerosol Delivery.J Aerosol Sci. 2014 Dec 1;78:11-29. doi: 10.1016/j.jaerosci.2014.08.003. J Aerosol Sci. 2014. PMID: 25308992 Free PMC article.
-
Development of an infant complete-airway in vitro model for evaluating aerosol deposition.Med Eng Phys. 2018 Jun 22:S1350-4533(18)30087-0. doi: 10.1016/j.medengphy.2018.05.002. Online ahead of print. Med Eng Phys. 2018. PMID: 29941306 Free PMC article.
-
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis.Pharmaceutics. 2025 Mar 7;17(3):347. doi: 10.3390/pharmaceutics17030347. Pharmaceutics. 2025. PMID: 40143011 Free PMC article.
-
Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):107-26. doi: 10.1089/jamp.2015.1270. Epub 2016 Feb 1. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26829187 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials